NEUROPACE, INC.
MOUNTAIN VIEW, CA

NeuroPace, Inc., founded in March 2016 and incorporated in Florida (Filed Number: F16000001158), is a key player in the medical device industry with its innovative RNS System designed to manage intractable epilepsy. This system incorporates a small implantable neurostimulator connected via leads to up to two seizure onset areas, working alongside a user-friendly home monitor and an integrated Patient Data Management System (PDMS). Frank Fischer, leveraging over 30 years of experience in senior management roles within medical devices, notably serves as Chief Executive Officer since the company's inception. His illustrious career spans various key roles including his tenure at Heartport, Inc., Ventritex, Inc., and Cordis Corporation. Underpinning its governance structure, NeuroPace is guided by executives such as Rebecca Kuhn, serving as Chief Financial Officer and Vice President of Finance and Administration since May 2000. Her extensive financial background includes contributions to the initial public offering of Heartport, Inc., alongside prior roles at Reebok International, Inc., and Arthur Andersen & Co. Dr. Martha M.D. Morrell oversees clinical operations as both Chief Medical Officer and Clinical Professor at Stanford University, drawing from her experiences as Director of the Columbia Comprehensive Epilepsy Center. Additionally, Andre Marquette, who joined in April 2017 as Chief Commercial Officer, brings over two decades of global healthcare commercial experience. Prior engagements with notable companies such as Visualase and St. Jude Medical reinforce his leadership capabilities in executing strategic business initiatives. Strategically based in Mountain View, CA (Mailing Address: 455 N. Bernardo Avenue), NeuroPace remains committed to patient education and support services, ensuring comprehensive accessibility for individuals utilizing the RNS System. This dedication is highlighted by their Patient Educators and Ambassadors who facilitate informed user engagement through various communication channels. Prospective insights into the company's operations are available on their website at neuropace.com. NeuroPace maintains a robust corporate presence with several registered offices across states such as CA, CO, FL; reflecting its expansive operation footprint in delivering groundbreaking epilepsy treatment solutions.

KEY FACTS ABOUT NEUROPACE, INC.

Company name
NEUROPACE, INC.
Status
Active
Filed Number
F16000001158
FEI Number
22-3550230
Date of Incorporation
March 10, 2016
Age - 10 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://neuropace.com
Phones
(866) 726-3876
(650) 237-2700
(650) 237-2701
(888) 646-8483

NEUROPACE, INC. NEAR ME

Principal Address
455 N. Bernardo Avenue,
Mountain View,
CA,
94043,
US

See Also

Officers and Directors

The NEUROPACE, INC. managed by the three persons from Mountain View on following positions: Trea, Chie, Director

Rebecca Kuhn

Position
Trea Active
From
Mountain View, CA, CA

Martha Morrell, M.D.

Position
Chie Active
From
Mountain View, CA, CA

Frank Fischer

Position
Director Active
From
Mountain View, CA, CA





Registered Agent is C T CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Annual Reports

2025
March 25, 2025
2024
April 29, 2024